Telepharmacy & CKD – A Making Tracks Investment Strategy · 2017-05-11 · Chronic Kidney Disease...
Transcript of Telepharmacy & CKD – A Making Tracks Investment Strategy · 2017-05-11 · Chronic Kidney Disease...
Telepharmacy & CKD – A Making Tracks Investment
Strategy Laura Johnstone
Pharmacist Cairns Hospital Renal Unit
August 2016
Outline
• Introduction • Methods • Results • Key Message
INTRODUCTION
Chronic Kidney Disease • 1.7 million Australians affected • 1.5 million don’t even know they have it
• $32.4 million per year to the health system - 5,000 hospital admissions - 110,000 doctor visits
CHHHS
TCHHS
Aboriginal and Torres Strait Islander Peoples
• Up to 4 times as likely to have late stage CKD • Those living in remote areas have up to 20
times higher incidence of end-stage renal failure
AND • 30 years younger
Making Tracks Investment Strategy
• Original publication in 2010 “Making Tracks towards closing the gap in health outcomes for Indigenous Queenslanders by 2033” • Launched 2015 - 2018 “Making Tracks investment strategy”
Making Tracks Investment Strategy
‘Preventing ill-health, improving diagnosis and early intervention, and better management and treatment of illness through the use of culturally and clinically effective healthcare.’
Making Tracks Investment Strategy
Priorities • Importance placed on preventative strategies • Multidisciplinary management for minimising
chronic disease • Improvement of health services by
implementing initiatives that increase access
Telepharmacy and CKD
• 3 Queensland Health staff members associated with the role
- Administration Officer - Clinical Nurse - Clinical Pharmacist
Aims of Telepharmacy and CKD • Increase access to a clinical pharmacy service • Contribute to reducing the burden of chronic disease • Deliver individualised and community-based CKD
management education • Improve the prevention, education, early detection
and diagnosis, treatment and self-management of CKD.
• Reduce hospitalisation rates for Aboriginal and Torres Strait Islander people with CKD.
METHODS
• Identification
• Appointment scheduled with site
• Appointment letter
• Telehealth Brochure
Telepharmacy Structure • Consent • Introduction • Attendees • Observations • Blood results • Medication review • Survey • Conclusion
Pharmacist documentation
• Integrated Electronic Medication Record (ieMR)
• Software for Specialists (Audit4) • Enterprise wide Liaison Medication System
(eLMS) • Mail/Fax/E-mail to local clinician
RESULTS
Results • Reporting period January to June 2016 • 129 booked telehealth appointments
• 82 successfully completed • 61% of patients identified as Aboriginal or Torres
Strait Islander
Results
• 667 Pharmacist interventions • Average of 8.1 per patient • 93.9% received education
Interventions Key
Code: Meaning: Code: Meaning:
IWS Indication Without Drug FRD Failed to Receive Drug
DWI Drug Without Indication LAB Inappropriate Lab Monitoring
IDS Improper Drug Selection MRD Medication Record Discrepancy
UD Under therapeutic Dose IE Inadequate Patient Education
OD Over therapeutic Dose IC Inadequate Patient Compliance
ADR Adverse Drug Reaction SI Medication Supply Issues
Results
Intervention: IWS DWI IDS IDI UD OD ADR LAB MRD IE IC
Total: 57 21 17 14 32 28 13 71 322 26 36
Yearly Growth
Year of reporting period OOS Number of Pharmacy Intervention
2015 38 147
2016 82 667
Satisfaction Survey
Survey Results
56.5%
41.2%
2.4%
Overall Experience:
Very Satisfied:
Satisfied:
Average:
KEY MESSAGE Telepharmacy is an invaluable health service to prevent CKD progression onto ESRD.
Patients with CKD living in rural and remote areas have a requirement for increased investment to promote awareness and provide education to prevent progression of this silent disease.